JP2007503210A5 - - Google Patents

Download PDF

Info

Publication number
JP2007503210A5
JP2007503210A5 JP2006524467A JP2006524467A JP2007503210A5 JP 2007503210 A5 JP2007503210 A5 JP 2007503210A5 JP 2006524467 A JP2006524467 A JP 2006524467A JP 2006524467 A JP2006524467 A JP 2006524467A JP 2007503210 A5 JP2007503210 A5 JP 2007503210A5
Authority
JP
Japan
Prior art keywords
slc6a7
polypeptide
gene
autism
mutation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006524467A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007503210A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2004/002995 external-priority patent/WO2005019474A2/en
Publication of JP2007503210A publication Critical patent/JP2007503210A/ja
Publication of JP2007503210A5 publication Critical patent/JP2007503210A5/ja
Pending legal-status Critical Current

Links

JP2006524467A 2003-08-22 2004-08-20 ヒト自閉症感受性遺伝子およびその使用 Pending JP2007503210A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US49691703P 2003-08-22 2003-08-22
US49690003P 2003-08-22 2003-08-22
PCT/IB2004/002995 WO2005019474A2 (en) 2003-08-22 2004-08-20 Human autism susceptibility gene and uses thereof

Publications (2)

Publication Number Publication Date
JP2007503210A JP2007503210A (ja) 2007-02-22
JP2007503210A5 true JP2007503210A5 (https=) 2007-10-04

Family

ID=34221427

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006524467A Pending JP2007503210A (ja) 2003-08-22 2004-08-20 ヒト自閉症感受性遺伝子およびその使用

Country Status (10)

Country Link
US (1) US20070134664A1 (https=)
EP (1) EP1656458B1 (https=)
JP (1) JP2007503210A (https=)
AT (1) ATE431855T1 (https=)
AU (1) AU2004267247B2 (https=)
CA (1) CA2535754A1 (https=)
DE (1) DE602004021186D1 (https=)
DK (1) DK1656458T3 (https=)
PT (1) PT1656458E (https=)
WO (1) WO2005019474A2 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0504096D0 (en) * 2005-02-28 2005-04-06 Tipogen As Method
WO2006124897A2 (en) * 2005-05-13 2006-11-23 Lexicon Genetics Incorporated Methods and compositions for improving cognition
CA2668811A1 (en) * 2006-11-07 2008-06-05 Lexicon Pharmaceuticals, Inc. Methods of treating cognitive impairment and dementia
EP2963129A3 (en) * 2008-11-12 2016-05-11 University of Utah Research Foundation Autism associated genetic markers
WO2010138796A2 (en) * 2009-05-29 2010-12-02 Genomind, Llc Methods for assessment and treatment of depression via utilization of single nucleotide polymorphisms analysis
US20110237537A1 (en) * 2009-05-29 2011-09-29 Lombard Jay L Methods for assessment and treatment of mood disorders via single nucleotide polymorphisms analysis
US8355927B2 (en) 2010-11-05 2013-01-15 Genomind, Llc Neuropsychiatric test reports
WO2011066132A1 (en) * 2009-11-24 2011-06-03 St. Jude Children's Research Hospital Use of sarcoplasmic ca2+-atpase type 2 protein for diagnosing and treating learning or mental disorders
WO2012078602A2 (en) * 2010-12-06 2012-06-14 Children's Medical Center Corporation Method for diagnosis and method of treatment of autism spectrum disorders and intellectual disability
US20140194310A1 (en) 2011-05-24 2014-07-10 Daniel H. Geschwind Genes dysregulated in autism as biomarkers and targets for therapeutic pathways
CN114019161B (zh) * 2021-11-08 2022-08-09 陕西脉元生物科技有限公司 抗camk2a自身抗体的试剂在制备诊断神经系统症状相关疾病的试剂盒中的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861719A (en) 1986-04-25 1989-08-29 Fred Hutchinson Cancer Research Center DNA constructs for retrovirus packaging cell lines
US5278056A (en) 1988-02-05 1994-01-11 The Trustees Of Columbia University In The City Of New York Retroviral packaging cell lines and process of using same
US5670488A (en) 1992-12-03 1997-09-23 Genzyme Corporation Adenovirus vector for gene therapy
DE69434860T2 (de) 1993-02-22 2007-03-15 The Rockefeller University Herstellung von helfer-freien retroviren mit hohem titer mittels transienter transfektion
FR2712812B1 (fr) 1993-11-23 1996-02-09 Centre Nat Rech Scient Composition pour la production de produits thérapeutiques in vivo.
IL116816A (en) 1995-01-20 2003-05-29 Rhone Poulenc Rorer Sa Cell for the production of a defective recombinant adenovirus or an adeno-associated virus and the various uses thereof
US6013516A (en) 1995-10-06 2000-01-11 The Salk Institute For Biological Studies Vector and method of use for nucleic acid delivery to non-dividing cells
US6228582B1 (en) * 1997-06-17 2001-05-08 University Of Rochester Genetic polymorphisms which are associated with autism spectrum disorders
AU3773099A (en) * 1998-04-29 1999-11-16 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Identification of polymorphisms in the pctg4 region of xq13
AU4989700A (en) * 1999-05-06 2000-11-21 Children's Hospital Of Los Angeles Autism gene
US20030152970A1 (en) * 2001-11-06 2003-08-14 Millennium Pharmaceuticals, Inc. Methods and compositions to treat pain and painful disorders using 577, 20739 or 57145
CA2364106A1 (fr) * 2001-11-30 2003-05-30 Christopher Gillberg Polynucleotide et proteine impliques dans la synaptogenese, variants de ceux-ci, et leurs applications therapeutiques et diagnostiques

Similar Documents

Publication Publication Date Title
Dasgupta et al. Mitochondrial DNA mutations in respiratory complex‐I in never‐smoker lung cancer patients contribute to lung cancer progression and associated with EGFR gene mutation
US10071129B2 (en) Method for identifying bromodomain inhibitors
Oshima Werner syndrome
US20090138204A1 (en) Single nucleotide polymorphisms sensitively predicting adverse drug reactions (ADR) and drug efficacy
JP2007503210A5 (https=)
WO2011160206A1 (en) Biomarkers for non-hodgkin lymphomas and uses thereof
Kohara et al. Identification of hypertension-susceptibility genes and pathways by a systemic multiple candidate gene approach: the millennium genome project for hypertension
EP2730663B1 (en) Genetic factors associated with inhibitor development in hemophilia A
Soupene et al. Requirement of the acyl-CoA carrier ACBD6 in myristoylation of proteins: Activation by ligand binding and protein interaction
King et al. Orientation of Pseudomonas aeruginosa ExsA monomers bound to promoter DNA and base-specific contacts with the P exoT promoter
JP2015502137A5 (https=)
EP1656458B1 (en) Human autism susceptibility gene and uses thereof
US20050123919A1 (en) Single nucleotide polymorphisms predicting adverse drug reactions and medication efficacy
JP2008504837A5 (https=)
Zieger et al. A novel PAR-1-type thrombin receptor signaling pathway: cyclic AMP-independent activation of PKA in SNB-19 glioblastoma cells
EP1828413A1 (en) Compositions and methods for treating mental disorders
JP2015159766A (ja) クッシング症候群の検査方法、検査用バイオマーカー及び治療剤
WO2005086872A2 (en) Ptpn22 polymorphisms in diagnosis and therapy
Wan et al. ATR preferentially interacts with common fragile site FRA3B and the binding requires its kinase activity in response to aphidicolin treatment
JP2008532499A5 (https=)
Arseniev et al. Single-molecule studies reveal the off-pathway elemental pause state as a target of streptolydigin inhibition of RNA polymerase and its dramatic enhancement by Gre factors
US8026063B2 (en) Method of examining inflammatory disease and method of screening remedy for imflammatory disease
CA2578072A1 (en) Compositions and methods for treating schizophrenia and related disorders
US20070265217A1 (en) Single Nucleotide Polymorphisms as Prognostic Tool to Diagnose Adverse Drug Reactions (Adr) and Drug Efficacy
JP7199691B2 (ja) カテプシンｅに強く結合し活性化するペプチド